Quarterly report pursuant to Section 13 or 15(d)

Financing (Details)

v3.20.1
Financing (Details) - USD ($)
1 Months Ended 3 Months Ended
Oct. 21, 2019
Sep. 18, 2018
Oct. 31, 2019
Jun. 30, 2020
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Nov. 30, 2019
Debt Instrument [Line Items]                
Repayments of related party debt         $ 150,000 $ 0    
NDX                
Debt Instrument [Line Items]                
Due to affiliate         200,000   $ 350,000  
NDX | Credit Agreement                
Debt Instrument [Line Items]                
Payments on Advance from NovellusDx, Ltd.   $ 1,500,000            
Repayments of related party debt $ 100,000   $ 1,000,000          
Long-term line of credit     $ 450,000          
Due to affiliate               $ 50,000
Conversion price (in usd per share)     $ 4.50          
Stated interest rate     0.00%          
Atlas Sciences                
Debt Instrument [Line Items]                
Stated interest rate     10.00%          
Debt instrument term     12 months          
Term note, principal balance     $ 1,300,000          
Gross consideration     1,300,000          
Debt issuance discount     88,000   31,000      
Interest and debt expense     10,000          
Maximum monthly redemption     $ 300,000          
Annual interest rate 22.00%              
Amount of principal exchanged         1,300,000      
Debt issuance costs         $ 3,000      
Forecast | NDX | Credit Agreement                
Debt Instrument [Line Items]                
Repayments of related party debt       $ 150,000